Newron Pharmaceuticals (NWPHF) Short Interest Ratio & Short Volume $9.36 0.00 (0.00%) (As of 11/22/2024 ET) Add Compare Share Share Short Interest Stock AnalysisChartHeadlinesShort Interest Newron Pharmaceuticals Short Interest DataNewron Pharmaceuticals (NWPHF) has a short interest of 84,200 shares. This marks a -32.15% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 600 shares to cover all short positions.Current Short Interest84,200 sharesPrevious Short Interest124,100 sharesChange Vs. Previous Month-32.15%Dollar Volume Sold Short$788,112.00Short Interest Ratio0.0 Days to CoverLast Record DateOctober 31, 2024Outstanding Shares17,850,000 sharesPercentage of Shares Shorted0.47%Today's Trading Volume0 sharesAverage Trading Volume600 sharesToday's Volume Vs. Average0% Short Selling Newron Pharmaceuticals? Sign up to receive the latest short interest report for Newron Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartNWPHF Short Interest Over TimeNWPHF Days to Cover Over TimeNWPHF Percentage of Float Shorted Over Time Ad Behind the Markets⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Click here for the ticker >>> Newron Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/31/202484,200 shares $788,112.00 -32.2%N/A0 $9.36 10/15/2024124,100 shares $1.16 million -0.6%N/A1241 $9.36 9/30/2024124,900 shares $1.17 million +29.8%N/A1249 $9.36 9/15/202496,200 shares $900,432.00 +0.3%N/A962 $9.36 8/31/202495,900 shares $872,690.00 +73.1%N/A0 $9.10 8/15/202455,400 shares $504,140.00 +1.3%N/A277 $9.10 Get the Latest News and Ratings for NWPHF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Newron Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 7/31/202454,700 shares $656,400.00 -30.8%N/A0 $12.00 7/15/202479,000 shares $948,000.00 +381.7%N/A0 $12.00 6/30/202416,400 shares $196,800.00 +10.1%N/A82 $12.00 6/15/202414,900 shares $142,295.00 No ChangeN/A74.6 $9.55 5/31/202414,900 shares $178,800.00 -0.7%N/A0 $12.00 5/15/202415,000 shares $180,000.00 -46.8%N/A75 $12.00 4/30/202428,200 shares $240,264.00 +28,100.0%N/A282 $8.52 4/15/2024100 shares $852.00 -99.8%N/A0 $8.52 3/31/202444,600 shares $379,992.00 +50.7%N/A0 $8.52 3/15/202429,600 shares $252,192.00 +60.0%N/A0 $8.52 2/29/202418,500 shares $157,620.00 +537.9%N/A0 $8.52 2/15/20242,900 shares $24,708.00 +480.0%N/A0 $8.52 1/15/20242,700 shares $21,330.00 -89.2%N/A6.8 $7.90 12/31/202324,900 shares $129,978.00 +66.0%N/A101.9 $5.22 12/15/202315,000 shares $93,300.00 -35.3%N/A0 $6.22 11/30/202323,200 shares $144,304.00 -27.0%N/A0 $6.22 11/15/202331,800 shares $197,796.00 +27.2%N/A0 $6.22 10/31/202325,000 shares $155,500.00 +24,900.0%N/A0 $6.22 10/15/2023100 shares $622.00 -99.5%N/A0 $6.22 9/30/202318,600 shares $115,692.00 -22.5%N/A0 $6.22 9/15/202324,000 shares $149,280.00 +566.7%N/A0 $6.22 8/31/20233,600 shares $22,392.00 -63.3%N/A35 $6.22 8/15/20239,800 shares $19,796.00 -10.9%N/A0 $2.02 7/31/202311,000 shares $22,220.00 +10,900.0%N/A0 $2.02 7/15/2023100 shares $202.00 No ChangeN/A1 $2.02 6/30/2023100 shares $202.00 No ChangeN/A0 $2.02 6/15/2023100 shares $202.00 No ChangeN/A0 $2.02 5/31/2023100 shares $202.00 -97.1%N/A0 $2.02 5/15/20233,500 shares $7,070.00 +3,400.0%N/A0 $2.02 4/30/2023100 shares $202.00 -99.5%N/A0 $2.02 4/15/202319,200 shares $38,784.00 -70.4%N/A0 $2.02 3/31/202364,900 shares $131,098.00 -35.5%N/A0 $2.02 3/15/2023100,600 shares $203,212.00 +21.5%N/A0 $2.02 2/28/202382,800 shares $167,256.00 +82,700.0%N/A828 $2.022024 Election Year Stocks: Uncover Hidden Gems! (Ad)In the lead-up to the pivotal 2024 election year, we're excited to present our comprehensive report, "Election Year Investment Gems: Stock Poised To Takeoff In 2024," brimming with insights and opportunities you won't want to miss.Secure your copy now by clicking this link. 2/15/2023100 shares $202.00 -91.7%N/A0 $2.02 1/31/20231,200 shares $2,424.00 +1,100.0%N/A0 $2.02 1/15/2023100 shares $202.00 No ChangeN/A1 $2.02 12/15/2022100 shares $210.00 No ChangeN/A0 $2.10 11/30/2022100 shares $210.00 No ChangeN/A0 $2.10 11/15/2022100 shares $210.00 No ChangeN/A0 $2.10 10/31/2022100 shares $210.00 No ChangeN/A0 $2.10 10/15/2022100 shares $210.00 No ChangeN/A0 $2.10 9/30/2022100 shares $210.00 No ChangeN/A0 $2.10 9/15/2022100 shares $210.00 No ChangeN/A0 $2.10 8/31/2022100 shares $210.00 No ChangeN/A0 $2.10 8/15/2022100 shares $210.00 No ChangeN/A0 $2.10 7/31/2022100 shares $210.00 No ChangeN/A0 $2.10 7/15/2022100 shares $210.00 No ChangeN/A0 $2.10 6/30/2022100 shares $210.00 No ChangeN/A0 $2.10 6/15/2022100 shares $210.00 No ChangeN/A0 $2.10 5/31/2022100 shares $210.00 No ChangeN/A0 $2.10 5/15/2022100 shares $210.00 No ChangeN/A0 $2.10 4/30/2022100 shares $210.00 No ChangeN/A0 $2.10 4/15/2022100 shares $210.00 No ChangeN/A0 $2.10 3/31/2022100 shares $210.00 No ChangeN/A0 $2.10 3/15/2022100 shares $210.00 No ChangeN/A0 $2.10 2/28/2022100 shares $210.00 No ChangeN/A0 $2.10 2/15/2022100 shares $210.00 No ChangeN/A0 $2.10 1/31/2022100 shares $210.00 No ChangeN/A0 $2.10 1/15/2022100 shares $210.00 No ChangeN/A0 $2.10 12/31/2021100 shares $210.00 No ChangeN/A0.3 $2.10 12/15/2021100 shares $280.00 No ChangeN/A0 $2.80 11/30/2021100 shares $280.00 No ChangeN/A0 $2.80 11/15/2021100 shares $280.00 No ChangeN/A0 $2.80 10/29/2021100 shares $280.00 No ChangeN/A0 $2.80 10/15/2021100 shares $280.00 No ChangeN/A0 $2.80 9/30/2021100 shares $280.00 No ChangeN/A0 $2.80 9/15/2021100 shares $280.00 No ChangeN/A0 $2.80 8/31/2021100 shares $280.00 -98.7%N/A0 $2.80 8/13/20217,700 shares $21,560.00 +7,600.0%N/A0 $2.80 7/30/2021100 shares $280.00 No ChangeN/A0 $2.80 7/15/2021100 shares $280.00 No ChangeN/A0 $2.80 6/30/2021100 shares $280.00 No ChangeN/A0 $2.80 6/15/2021100 shares $280.00 No ChangeN/A0.1 $2.80 5/28/2021100 shares $280.00 No ChangeN/A1 $2.80 5/14/2021100 shares $280.00 No ChangeN/A0 $2.80 4/30/2021100 shares $280.00 No ChangeN/A0 $2.80 4/15/2021100 shares $280.00 No ChangeN/A0 $2.80 3/31/2021100 shares $300.00 -98.1%N/A0.5 $3.00 3/15/20215,300 shares $12,935.18 +5,200.0%N/A2.8 $2.44 2/26/2021100 shares $244.06 No ChangeN/A0 $2.44 2/12/2021100 shares $244.06 -92.9%N/A0 $2.44 1/29/20211,400 shares $3,416.84 +1,300.0%N/A0 $2.44 1/15/2021100 shares $244.06 No ChangeN/A0 $2.442024 Election Year Stocks: Uncover Hidden Gems! (Ad)In the lead-up to the pivotal 2024 election year, we're excited to present our comprehensive report, "Election Year Investment Gems: Stock Poised To Takeoff In 2024," brimming with insights and opportunities you won't want to miss.Secure your copy now by clicking this link. 12/31/2020100 shares $244.06 No ChangeN/A0.1 $2.44 12/15/2020100 shares $247.00 No ChangeN/A0 $2.47 11/30/2020100 shares $196.29 No ChangeN/A0 $1.96 11/15/2020100 shares $196.29 No ChangeN/A0.1 $1.96 10/30/2020100 shares $190.00 No ChangeN/A1 $1.90 10/15/2020100 shares $202.00 -93.8%N/A0.5 $2.02 9/30/20201,600 shares $4,080.00 +1,500.0%N/A0 $2.55 9/15/2020100 shares $255.00 No ChangeN/A0 $2.55 8/31/2020100 shares $255.00 -90.0%N/A1 $2.55 8/14/20201,000 shares $2,500.00 +900.0%N/A10 $2.50 7/31/2020100 shares $181.00 No ChangeN/A0 $1.81 7/15/2020100 shares $181.00 No ChangeN/A0 $1.81 6/30/2020100 shares $181.00 No ChangeN/A0.2 $1.81 6/15/2020100 shares $180.10 No ChangeN/A0.2 $1.80 5/29/2020100 shares $890.00 No ChangeN/A1 $8.90 5/15/2020100 shares $750.00 -99.3%N/A1 $7.50 4/30/202014,000 shares $105,000.00 +25.0%N/A0 $7.50 4/15/202011,200 shares $84,000.00 -69.1%N/A0 $7.50 3/31/202036,200 shares $271,500.00 +44.8%N/A0 $7.50 3/13/202025,000 shares $187,500.00 No ChangeN/A250 $7.50 2/28/202025,000 shares $187,500.00 No ChangeN/A0 $7.50 2/14/202025,000 shares $187,500.00 No ChangeN/A0 $7.50 1/31/202025,000 shares $187,500.00 No ChangeN/A0 $7.50 1/15/202025,000 shares $187,500.00 -1.2%N/A250 $7.50 12/31/201925,300 shares $189,750.00 -41.4%N/A0 $7.50 NWPHF Short Interest - Frequently Asked Questions What is Newron Pharmaceuticals' current short interest? Short interest is the volume of Newron Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of October 31st, investors have sold 84,200 shares of NWPHF short. Learn More on Newron Pharmaceuticals' current short interest. Is Newron Pharmaceuticals' short interest increasing or decreasing? Newron Pharmaceuticals saw a drop in short interest in the month of October. As of October 31st, there was short interest totaling 84,200 shares, a drop of 32.2% from the previous total of 124,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Newron Pharmaceuticals' short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Newron Pharmaceuticals: Elite Pharmaceuticals, Inc. (0.15%), Arbutus Biopharma Co. (3.45%), Phathom Pharmaceuticals, Inc. (25.52%), ORIC Pharmaceuticals, Inc. (16.51%), CorMedix Inc. (10.35%), AnaptysBio, Inc. (23.75%), Stoke Therapeutics, Inc. (12.65%), Altimmune, Inc. (32.26%), Dianthus Therapeutics, Inc. (25.20%), Oculis Holding AG (0.06%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks. What does it mean to sell short Newron Pharmaceuticals stock? Short selling NWPHF is an investing strategy that aims to generate trading profit from Newron Pharmaceuticals as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Newron Pharmaceuticals? A short squeeze for Newron Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of NWPHF, which in turn drives the price of the stock up even further. How often is Newron Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NWPHF, twice per month. The most recent reporting period available is October, 31 2024. More Short Interest Resources from MarketBeat Related Companies Elite Pharmaceuticals Short Squeeze Arbutus Biopharma Short Squeeze Phathom Pharmaceuticals Short Squeeze ORIC Pharmaceuticals Short Squeeze CorMedix Short Squeeze AnaptysBio Short Squeeze Stoke Therapeutics Short Squeeze Altimmune Short Squeeze Dianthus Therapeutics Short Squeeze Oculis Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:NWPHF) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Newron Pharmaceuticals S.p.A. Please log in to your account or sign up in order to add this asset to your watchlist. Share Newron Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.